Latest filing published 11 Dec 2024 for Palo Alto Networks Inc.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +0.5%Entry US$41.52 · Close at T+365 US$41.71
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Helene D. Gayle: trading record in brief
Helene D. Gayle sits as a Director at Colgate Palmolive Co (35 filings), Palo Alto Networks Inc (4) and GoHealth, Inc. (1). The record of 40 filings is published from May 11, 2016 to December 11, 2024 and holds no filing in the last twelve months.
The 4 sales, all at Colgate Palmolive Co, come to EUR 2,296,002, with a median of EUR 368,856. One carries the weight: EUR 1,540,584 on February 7, 2020. The next two are EUR 372,192 on May 3, 2019 and EUR 365,520 on May 10, 2018. No purchase is recorded. The rest is 28 grants and 8 option exercises.
The peak is 12 filings in 2020, after 7 a year from 2017 to 2019. The volume falls back to 3 in 2021, then to a single filing a year from 2022 to 2024. Filings come out a median of 2 days after the trade.
At Colgate Palmolive Co, 4 of Gayle's trades are close to trades by John J. Huston, 3 to trades by Daniel B. Marsili, Ian M. Cook and Noel R. Wallace, within 30 days and in the same direction.
Companies and markets linked to Helene D. Gayle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 915 shares0Common StockSEC:0000950170-24-135529:0
- 1,308 shares0Common StockSEC:0001209191-23-058494:0
- 2,157 shares0Common StockSEC:0001209191-22-061313:0
- 2,890 shares0Common StockSEC:0001209191-21-035935:0
- 228 shares@ US$76.480.3% of flowCommon StockSEC:0001225208-21-006475:0
- 205 shares@ US$85.100.3% of flowCommon StockSEC:0001225208-21-000327:0
- 228 shares@ US$76.680.5% of flowCommon StockSEC:0001225208-20-012213:0
- 7,143 shares0Class A Common StockSEC:0000899243-20-019530:0
- 240 shares@ US$72.820.5% of flowCommon StockSEC:0001225208-20-009510:0
- 2,594 shares0Common StockSEC:0001225208-20-007606:0
- 260 shares@ US$67.310.5% of flowCommon StockSEC:0001225208-20-006069:0
- 5,583 shares@ US$67.8311.4% of flowCommon StockSEC:0001225208-20-001940:0
- 5,389 shares@ US$71.7611.6% of flowCommon StockSEC:0001225208-20-001940:1
- 5,357 shares@ US$67.1910.8% of flowCommon StockSEC:0001225208-20-001940:2
- 3,802 shares@ US$71.658.2% of flowCommon StockSEC:0001225208-20-001940:3
- 2,109 shares@ US$62.043.9% of flowCommon StockSEC:0001225208-20-001940:4
- 22,240 shares@ US$76.0850.9% of flowCommon StockSEC:0001225208-20-001940:5
- 256 shares@ US$68.250.4% of flowCommon StockSEC:0001225208-20-000553:0
- 241 shares@ US$72.440.4% of flowCommon StockSEC:0001225208-19-013193:0
- 240 shares@ US$72.670.3% of flowCommon StockSEC:0001225208-19-010058:0
- 2,515 shares0Common StockSEC:0001225208-19-008058:0
- 5,780 shares@ US$71.958.4% of flowCommon StockSEC:0001223203-19-000021:1
- 5,780 shares@ US$60.457.0% of flowCommon StockSEC:0001223203-19-000021:0
- 264 shares@ US$66.220.4% of flowCommon StockSEC:0001225208-19-006348:0
- 281 shares@ US$62.240.3% of flowCommon StockSEC:0001225208-19-000454:0
25 of 50 declarations
